Zeto is commercializing a wireless dry-electrode headset for EEGs.
Zeto Raises $7.3M in Series A Funding

Zeto is commercializing a wireless dry-electrode headset for EEGs.
“These 15 companies embody the drive to make a significant difference in people’s lives, by any technological means at their disposal.”
The collaboration is aimed at fundamentally improving the control and accuracy of minimally invasive interventional medical procedures.
The funding will speed commercialization, pending FDA approval, and support R&D for remote infection monitoring applications.
Verana plans further expansions into imaging, genomic, and claims data.
Patients with newly diagnosed malignant brain tumors are now eligible for surgically targeted radiation therapy.
Velano’s PIVO device allows practitioners to collect as much blood as needed while the patient is in the hospital without additional needle sticks.
Raydiant is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth.
Raydiant Oximetry Sensing Systems is a novel, non-invasive technology that more accurately detects fetal distress during labor and delivery.
Early-stage health tech companies chosen for their innovative technology and high growth potential.